Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis

PHASE2RecruitingINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

November 30, 2025

Conditions

Eosinophilic Esophagitis

Interventions

DRUG

Florence 30 μg/mL

10 mL, oral, twice a day.

DRUG

Florence 60 μg/mL

10 mL, oral, twice a day.

DRUG

Florence 90 μg/mL

10 mL, oral, twice a day.

OTHER

Placebo

10 mL, oral, twice a day.

Trial Locations (1)

RECRUITING

Allergisa, Campinas